Toumaz Technology named emerging technology company of the year
25 November 2009
Toumaz Technology Limited, producer of ultra-low power
wireless infrastructure for body monitoring solutions has been named
“Emerging Technology Company of the Year” by the National
Microelectronics Institute (NMI), the premier trade association
representing the semiconductor industry in the UK and Ireland.
The Award, sponsored by Toshiba, is given to an established company
that demonstrates revolutionary or new technology in an emerging market,
or a new product in an existing market, and rewards both technology and
Toumaz’s award was given in recognition of its Sensium technology
platform for the development of body monitoring solutions that are
wireless, intelligent, continuous and low-cost. The NMI Award judges
were particularly impressed with the performance of the technology for
revolutionary healthcare products, offering 10x better low power
performance than today’s low power networking standards. By delivering
long battery life time and portability, the judges recognised that
Sensium-enabled products make living with continuous monitoring
significantly easier for patients.
Now in its 7th year, the NMI Annual Awards Dinner, which was held on
5 November, is regarded as one of the semiconductor industry's most
prestigious events and this year attracted 300 guests from throughout
the UK and around the world. The NMI industry awards recognise the
achievements and behaviours that are conducive to a healthy and vibrant
industry in the UK and Ireland.
Nine NMI Award Winners were announced on the night. In 2006, Toumaz
Technology had the distinction of being named the inaugural winner of
“NMI Start-up of the Year”.
In October 2009, Toumaz announced that it had achieved CE-marking for
its Sensium Life Pebble, a non-intrusive, body-worn wireless vital signs
monitor that delivers real-time, high-quality data for healthcare
Earlier this month, Toumaz announced that it has begun a landmark
clinical trial of its Sensium 'digital plaster' wireless body monitor.
The study, which is expected to demonstrate the high quality
physiological data that can be continuously acquired by wireless,
unobtrusive Sensium-enabled devices, is being conducted by a specialist
clinical research team at St Mary’s Hospital (part of Imperial College
Healthcare NHS Trust).
Commenting on this year’s award win, Toumaz Holdings CEO Professor
Chris Toumazou FRS said: “We are thrilled to have been given this
special honour by the NMI in recognition of the truly revolutionary
nature of our Sensium technology and its emergence in some very exciting
commercial applications. We are delighted to accept this coveted and
important award from our leading industry body.”